Skip to content

The Effect of Functional Electrical Stimulation Intervention in Treatment of Older Adults with COVID-19

The Effect of Functional Electrical Stimulation Intervention on Fatigue, Muscle Strength, Muscle Mass and Quality of Life in Older Adults with COVID-19

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201102049234N2
Enrollment
40
Registered
2021-10-26
Start date
2021-10-02
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus disease (COVID-19). COVID-19, virus identified

Interventions

Intervention 1: Intervention group: The first group will receive functional electrical stimulation during 10 sessions of rehabilitation treatment. The patient will sit on a chair. FES will apply bilat

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Elderly People with COVID-19 After Hospital Discharge Age Over 60 Years Obvious Atrophy of the Quadriceps and Tibialis Anterior Muscles Normal Level of Alertness ,Orientation and Responsiveness to Verbal Stimulus To Be Willing to Participate in the Study

Exclusion criteria

Exclusion criteria: Pregnancy Known or Suspected Malignancy in the Lower Limb Body Mass Index Equal or Greater than 35 Kilogram Per Square Meter Conditions Preventing Electrical Stimulation Treatment for Example Deep Vein Thrombosis and Rhabdomyolysis Skin Lesions at the Site of Electrical Stimulation Diagnosis of Alzheimer's Disease, Degenerative Disease and Polyneuropathy Conditions Preventing Outcome Assessment for Example Amputation or Inability to Walk Presence of an Implanted Cardiac Pacemaker or Defibrillator

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: Before the intervention and after the end of intervention. Method of measurement: Chalder fatigue questionnaire.;Muscle Strength. Timepoint: Before the intervention and after the end of intervention. Method of measurement: Biofeedback pressure device.;Muscle Mass. Timepoint: Before the intervention and after the end of intervention. Method of measurement: Ultrasonographic device.;Quality of Life. Timepoint: Before the intervention and one month after the start of intervention. Method of measurement: WHOQOL-BREF questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Ramezani

Semnan University of Medical Sciences

mona.ramezani.sa@gmail.com+98 23 8502 3332

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026